| Literature DB >> 36034966 |
Paul Ochieng Nyalo1,2, George Isanda Omwenga1, Mathew Piero Ngugi1.
Abstract
Bacterial diseases are a leading cause of mortality and morbidity globally. During bacterial diseases, an elevation of host immune response occurs, which involves the production of free radicals in response to the bacterial infection. The overproduction of free radicals in excess of the antioxidants leads to oxidative stress. Conventional antibiotics are linked to side effects such as hypersensitivity reactions in addition to bacterial pathogens developing resistance against them. Artificial antioxidants are said to be carcinogenic. This study sought to confirm folklore use and validate the antibacterial and antioxidant potential of Senna singueana which has been widely used in the Mbeere community. The in vitro antibacterial potentials of the plant extract were investigated on Bacillus subtilis ATCC 21332, Escherichia coli ATCC 25922, Salmonella typhi ATCC 1408, and Staphylococcus aureus ATCC 25923. Ciprofloxacin (100 µg/ml) drug was used as a standard reference, whereas 5% DMSO was used as a negative reference. The antibacterial tests included disc diffusion and minimum inhibitory and bactericidal concentrations. S. singueana ethyl acetate extract showed broad-spectrum potential against tested bacterial microbes producing mean zones of inhibition (MZI) from 07.67 ± 0.33 to 17.67 ± 0.33 mm. The extract demonstrated a greater effect on Gram-positive than Gram-negative bacterial pathogens. Antibacterial properties of ciprofloxacin were significantly greater in comparison to plant extract in all the dilutions (p < 0.05), while 5% DMSO was inactive against all the tested bacteria. MBC values were greater than MIC values. Antioxidant properties of the extract were determined through scavenging effects of DPPH and hydroxyl radicals (•OH) as well as ferric reducing antioxidant potential (FRAP) assay. S. singueana demonstrated effects against all radicals formed. Additionally, the extract exhibited ferric reducing abilities. The extract also contained various phytocompounds with known antibacterial and antioxidant properties. This study recommends the therapeutic use of S. singueana as an antibacterial as well as an antioxidant agent.Entities:
Year: 2022 PMID: 36034966 PMCID: PMC9410794 DOI: 10.1155/2022/5436476
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.650
Figure 1Inhibition zones caused by Senna singueana extract on S. aureus.
Antibacterial properties of ethyl acetate leaf extracts of S. singueana.
| Treatment | Zones of inhibition (mm) | |||
|---|---|---|---|---|
| 5% DMSO |
|
|
|
|
| Ciprofloxacin (100 | 06.00 ± 0.00g | 06.00 ± 0.00g | 06.00 ± 0.00d | 06.00 ± 0.00d |
|
| 26.33 ± 0.33a | 29.67 ± 0.33a | 32.67 ± ±0.33a | 28.33 ± 0.33a |
| (mg/ml) | ||||
| 100 | 17.67 ± 0.33b | 17.67 ± 0.33b | 09.67 ± 0.33b | 10.67 ± 0.33b |
| 50 | 15.33 ± 0.33c | 14.33 ± 0.33c | 08.67 ± 0.33bc | 09.67 ± 0.33b |
| 25 | 13.67 ± 0.33cd | 12.33 ± 0.33d | 07.67 ± 0.33c | 07.67 ± 0.33c |
| 12.5 | 12.67 ± 0.33de | 10.67 ± 0.33e | 06.00 ± 0.00d | 06.00 ± 0.00d |
| 6.25 | 10.67 ± 0.67ef | 09.67 ± 0.33ef | 06.00 ± 0.00d | 06.00 ± 0.00d |
| 3.125 | 09.33 ± 0.88f | 08.33 ± 0.33f | 06.00 ± 0.00d | 06.00 ± 0.00d |
The values of mean zones of inhibition (MZI) are conveyed as mean ± std error of mean. Values having similar superscripts within a particular column are insignificantly distinct after one-way analysis of variance and Tukey's post hoc (p < 0.05).
Minimum inhibitory concentration of S. singueana extract.
| Concentration (mg/ml) | ||
|---|---|---|
| Bacterial strain | S. | Ciprofloxacin ( |
|
| 1.30 ± 0.26b | 0.16 ± 0.03a |
|
| 3.13 ± 0.00b | 0.16 ± 0.03a |
|
| 41.67 ± 8.33a | 0.13 ± 0.03a |
|
| 20.83 ± 4.17ab | 0.05 ± 0.00a |
Values were conveyed as mean ± std error of mean. Values having similar superscript letters within a particular column are insignificantly distinct (p < 0.05) (two-sample T-test). p < 0.05.
Comparison of MICs of the studied ethyl acetate extract and Ciprofloxacin.
| Minimum inhibition concentration (mg/ml) | ||||
|---|---|---|---|---|
| Treatment |
|
|
|
|
| Ciprofloxacin ( | 0.16 ± 0.03b | 0.16 ± 0.03b | 0.13 ± 0.03b | 0.05 ± 0.00b |
|
| 1.30 ± 0.26a | 3.13 ± 0.00a | 41.67 ± 8.33a | 20.83 ± 4.17a |
Values were conveyed as mean±std error of mean. Values having similar superscript letters within a particular column are insignificantly distinct (p < 0.05) (two-sample T-test).
Minimum bactericidal concentration of S. singueana extract.
| Concentration (mg/ml) | ||
|---|---|---|
| Bacterial strains |
| Ciprofloxacin ( |
|
| 12.50 ± 0.00c | 1.30 ± 0.26a |
|
| 41.67 ± 8.33b | 0.65 ± 0.13ab |
|
| 100.00 ± 0.00a | 0.78 ± 0.00ab |
|
| 100.00 ± 0.00a | 0.26 ± 0.06b |
Values were conveyed as mean ± std error of mean. Values having similar superscript letters within a particular column are insignificantly distinct after one-way analysis of variance and Tukey's post hoc (p < 0.05).
Comparison of MBC of the studied ethyl acetate extract and Ciprofloxacin.
| Minimum bactericidal concentration (mg/ml) | ||||
|---|---|---|---|---|
| Treatment |
|
|
|
|
| Ciprofloxacin ( | 1.30 ± 0.26b | 0.65 ± 0.13b | 0.78 ± 0.00b | 0.26 ± 0.06b |
|
| 12.50 ± 0.00a | 41.67 ± 8.33a | 100.00 ± 0.00a | 100.00 ± 0.00a |
Values were conveyed as mean ± std error of mean. Values having similar superscript letters within a particular column are insignificantly distinct (p < 0.05) (two-sample T-test).
Figure 2In vitro DPPH radical quenching properties of S. singueana extract. Bar graphs having identical letters across the tested concentrations are statistically similar (p < 0.05) (one-way ANOVA and Tukey's post hoc tests). Within the same concentration, bar graphs without asterisks () are significantly distinct (p < 0.05) (two-Sample T-Test).
Figure 3Ferric reducing potential of S. singueana extract. Bar graphs with identical letter/s across the tested concentrations are statistically similar (p > 0.05) (one-way ANOVA and Tukey's post hoc tests). Within the same concentration, bar graphs without asterisks () are significantly distinct (p < 0.05) (two-sample T-Test).
Quantitative phytochemical compound analysis in ethyl acetate extract of S. singueana.
| RT (mins) | Compound | %abundance | MF | MW (g/mol) | Conc ( | Chemical Class |
|---|---|---|---|---|---|---|
| 38.78 |
| 0.28 | C29H50O | 414.70 | 0.17 ± 0.00 | Steroid |
| 44.42 |
| 0.09 | C14H12N2 | 208.26 | 0.06 ± 0.00 | Heteroaromatic molecule |
| 47.31 | 1(3H) | 0.09 | C19H18O6 | 342.30 | 0.05 ± 0.00 | Volatile |
| 46.71 | 1,2,3 | 0.24 | C11H13NO3 | 207.00 | 0.14 ± 0.00 | Hydrocarbon |
| 27.34 | 1,4-Dioxaspiro [4.5]decane | 2.53 | C11H19NO3 | 213.27 | 1.51 ± 0.02 | Cyclohexane |
| 21.79 | 1-Cyclopentyleicosane | 0.57 | C25H50 | 350.70 | 0.34 ± 0.00 | Hydrocarbon |
| 27.06 | 1-Hexadecanol, 3,7,11,15-tetramethyl- | 0.95 | C20H42O | 298.50 | 0.57 ± 0.01 | Terpene alcohol |
| 44.18 | 2-(Acetoxymethyl)-3-(methoxycarbonyl)biphenylene | 0.72 | C17H14O4 | 282.29 | 0.43 ± 0.01 | Hydrocarbon |
| 13.72 | 2-Cyclohexylpiperidine | 0.05 | C11H21N | 167.29 | 0.03 ± 0.00 | Alkaloid |
| 46.38 | 2-Pyridinamine, N-(4, 5-dihydro-5-methyl-2-thiazolyl)-3-methyl- | 0.15 | C10H13N3S | 207.29 | 0.09 ± 0.00 | Aminopyridine |
| 29.69 | 3,7,11,15 | 5.57 | C20H40O | 296.50 | 3.32 ± 0.04 | Terpene alcohol |
| 21.51 | 4-Nonanol, 2,6,8-trimethyl- | 0.56 | C12H26O | 186.33 | 0.33 ± 0.00 | Fatty alcohol |
| 49.10 | 5-(2-Oxo-6-phenyl-1,2-dihydropyrimidinyl-4)uracil | 0.02 | not found | 0.01 ± 0.00 | ||
| 25.51 | 7-Octenal, 3,7-dimethyl- | 1.78 | C10H18O | 154.25 | 1.06 ± 0.01 | Monoterpenoid |
| 25.06 | 9-Octadecenoic acid, methyl ester, (E)- | 2.05 | C19H36O2 | 296.50 | 1.22 ± 0.02 | Fatty acid methyl ester |
| 28.18 | 9-Tricosene, (Z)- | 4.53 | C23H46 | 322.60 | 2.70 ± 0.04 | Hydrocarbon |
| 44.35 | Acetamide, N-methyl-N-(2-phenylethyl)- | 0.28 | C11H15NO | 177.24 | 0.17±0.00 | Benzene derivative |
| 03.39 | Butane, 2-chloro-2-methyl- | 0.33 | C5H11Cl | 106.59 | 0.20 ± 0.00 | Alkyl chloride /chlorinated hydrocarbon |
| 16.95 | Cyclohexadecane, 1,2-diethyl- | 0.52 | C20H40 | 280.50 | 0.31 ± 0.00 | Hydrocarbon |
| 23.37 | Decane, 3,8-dimethyl- | 0.41 | C12H26 | 170.33 | 0.24 ± 0.00 | Hydrocarbon |
| 25.88 | Docosane | 3.51 | C22H46 | 310.60 | 2.09 ± 0.03 | Hydrocarbon |
| 19.40 | Dodecane, 2,6,11-trimethyl | 0.68 | C15H32 | 212.41 | 0.40 ± 0.01 | Aliphatic alkane |
| 20.16 | Dodecanoic acid | 4.17 | C12H24O2 | 200.32 | 2.48 ± 0.03 | Fatty acid |
| 19.65 | Dodecanoic acid, methyl ester | 0.72 | C13H26O2 | 214.34 | 0.43 ± 0.01 | Fatty acid methyl ester |
| 21.64 | Eicosane (C20) | 0.95 | C20H42 | 282.50 | 0.57 ± 0.01 | Hydrocarbon |
| 30.38 | Fumaric acid,4-methyl pent-2-yl tridecyl ester | 1.28 | C23H42O4 | 382.58 | 0.76 ± 0.01 | Fatty acid ester |
| 29.14 | Hexacosane | 3.44 | C26H54 | 366.70 | 2.05 ± 0.03 | Hydrocarbon |
| 29.89 | Hexadecane (C16) | 4.50 | C16H34 | 226.44 | 2.68 ± 0.04 | Hydrocarbon |
| 34.24 | Hexadecane, 8-hexyl-8-pentyl- | 1.82 | C27H56 | 380.70 | 1.08 ± 0.01 | Hydrocarbon |
| 24.07 | Hexadecanoic acid, ethyl ester | 2.31 | C18H36O2 | 284.50 | 1.38 ± 0.02 | Fatty acid ester |
| 24.33 | Isopropyl hexadecanoate | 1.01 | C19H38O2 | 298.50 | 0.60 ± 0.01 | Fatty acid ester |
| 40.55 | Lupan-3-ol | 0.33 | C30H52O | 428.40 | 0.20 ± 0.00 | Tritepenoid |
| 23.46 | Methyl hexadecanoate | 1.60 | C17H34O2 | 270.50 | 0.95 ± 0.01 | Fatty acid methyl ester |
| 18.88 | Methyleugenol | 0.52 | C11H14O2 | 178.23 | 0.31 ± 0.00 | Phenylpropanoid |
| 23.84 | n-Hexadecanoic acid | 1.48 | C16H32O2 | 256.42 | 0.88 ± 0.01 | Fatty acid dervivative |
| 26.73 | Nonadecane (C19) | 2.61 | C19H40 | 268.50 | 1.50 ± 0.02 | Hydrocarbon |
| 30.72 | Octacosane | 3.41 | C28H58 | 394.80 | 2.03 ± 0.03 | Hydrocarbon |
| 06.68 | Oxazolidine, 2-ethyl-2-methyl- | 0.03 | C6H13NO | 115.17 | 0.02 ± 0.00 | Oxazoline compound |
| 28.37 | Pentacosane | 3.63 | C25H52 | 352.70 | 2.16 ± 0.03 | Hydrocarbon |
| 28.65 | Phenol, 2,4 | 2.81 | C24H26O | 330.50 | 1.67 ± 0.02 | Phenolic compound |
| 25.21 | Phytol | 3.54 | C20H40O | 296.50 | 2.11 ± 0.03 | Diterpenoid |
| 26.08 | Phytol acetate<E-> | 3.34 | C22H42O2 | 338.60 | 1.99 ± 0.03 | Diterpenoid |
| 10.55 | Pyrrolidine, 2-decyl-1-methyl- | 0.07 | C17H35N | 253.50 | 0.04 ± 0.00 | Cyclic secondary amine |
| 31.07 | Squalene | 8.79 | C30H50 | 410.70 | 5.24 ± .07 | Triterpenoid |
| 32.85 | Tetracosane | 8.48 | C24H50 | 338.70 | 5.05 ± 0.03 | Hydrocarbon |
| 25.72 | Tetratetracontane | 2.40 | C44H90 | 619.20 | 1.43 ± 0.02 | Hydrocarbon |
| 31.70 | Tricosane | 5.72 | C23H48 | 324.60 | 3.41 ± 0.05 | Hydrocarbon |
| 21.19 | Tridecane, 1-iodo- | 1.03 | C13H27I | 310.26 | 0.61 ± 0.01 | Iodo compound |
| 24.21 | Undecane, 5,5-dimethyl- | 0.83 | C13H28 | 184.36 | 0.50 ± 0.01 | Hydrocarbon |
| 35.06 | Vitamin E | 3.26 | C29H50O2 | 430.70 | 1.94 ± 0.03 | Tocopherol |
Conc, concentration; Mins, minutes; MF, molecular formula; RT, retention time; MW, molecular weight.